Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Beck

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Brain : a Journal of Neurology|October 2, 2010
Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibitionChristian Geis, Andreas Weishaupt, Stefan Hallermann, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2025
Trends and efficacy of definitive radiotherapy regimens for locally advanced head and neck cancer in elderly patients: A population-based analysis by the German cancer registry groupInge Tinhofer, Elena Hofmann, Anna Trelinska-Finger, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 22, 2022
Tetramodal therapy with transurethral resection followed by chemoradiation in combination with hyperthermia for muscle-invasive bladder cancer: early results of a multicenter phase IIB studyOliver Riesterer, Adela Ademaj, Emsad Puric, et al.
European Urology|January 6, 2026
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: Long-term Data from the SAKK 09/10 Randomised Phase 3 TrialPirus Ghadjar, Stefanie Hayoz, Daniel R Zwahlen, et al.
Clinical and Translational Radiation Oncology|May 6, 2024
Erectile function preservation after salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: Five-year results of the SAKK 09/10 randomized phase 3 trialDaniel R Zwahlen, Christina Schröder, Lisa Holer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 10, 2025
Long-term urinary continence and influencing factors after salvage radiotherapy: results of the SAKK 09/10 dose escalation trialChristina Schröder, Daniel R Zwahlen, Sämi Schär, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 23, 2024
Regional hyperthermia for soft tissue sarcoma - a survey on current practice, controversies and consensus among 12 European centersSiyer Roohani, Felix Ehret, Marcus Beck, et al.
International Journal of Radiation Oncology, Biology, Physics|January 6, 2022
Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trialMarcus Beck, Manfred Sassowsky, Sämi Schär, et al.
Frontiers in Oncology|April 7, 2023
Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trialSusanne Wiegand, Gunnar Wichmann, Jeannette Vogt, et al.
Brain : a Journal of Neurology|April 19, 2007
Large-scale pathways-based association study in amyotrophic lateral sclerosisDalia Kasperaviciute, Mike E Weale, Kevin V Shianna, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Brain : a Journal of Neurology|October 2, 2010
Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibitionChristian Geis, Andreas Weishaupt, Stefan Hallermann, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2025
Trends and efficacy of definitive radiotherapy regimens for locally advanced head and neck cancer in elderly patients: A population-based analysis by the German cancer registry groupInge Tinhofer, Elena Hofmann, Anna Trelinska-Finger, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 22, 2022
Tetramodal therapy with transurethral resection followed by chemoradiation in combination with hyperthermia for muscle-invasive bladder cancer: early results of a multicenter phase IIB studyOliver Riesterer, Adela Ademaj, Emsad Puric, et al.
European Urology|January 6, 2026
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: Long-term Data from the SAKK 09/10 Randomised Phase 3 TrialPirus Ghadjar, Stefanie Hayoz, Daniel R Zwahlen, et al.
Clinical and Translational Radiation Oncology|May 6, 2024
Erectile function preservation after salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: Five-year results of the SAKK 09/10 randomized phase 3 trialDaniel R Zwahlen, Christina Schröder, Lisa Holer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 10, 2025
Long-term urinary continence and influencing factors after salvage radiotherapy: results of the SAKK 09/10 dose escalation trialChristina Schröder, Daniel R Zwahlen, Sämi Schär, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 23, 2024
Regional hyperthermia for soft tissue sarcoma - a survey on current practice, controversies and consensus among 12 European centersSiyer Roohani, Felix Ehret, Marcus Beck, et al.
International Journal of Radiation Oncology, Biology, Physics|January 6, 2022
Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trialMarcus Beck, Manfred Sassowsky, Sämi Schär, et al.
Frontiers in Oncology|April 7, 2023
Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trialSusanne Wiegand, Gunnar Wichmann, Jeannette Vogt, et al.
Brain : a Journal of Neurology|April 19, 2007
Large-scale pathways-based association study in amyotrophic lateral sclerosisDalia Kasperaviciute, Mike E Weale, Kevin V Shianna, et al.
Pageof 8